JENNIFER BERRY: Open Payments
NPI 1144544636 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,196 in 187 payments from 43 companies in 2025. Trend: 2023 $4,621 · 2024 $4,125 · 2025 $4,196
Food & beverage: $4,113Education: $83
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $391 |
| Merck Sharp & Dohme LLC | 12 | $312 |
| AstraZeneca Pharmaceuticals LP | 10 | $277 |
| Janssen Biotech, Inc. | 10 | $270 |
| ABBVIE INC. | 11 | $221 |
| Gilead Sciences, Inc. | 4 | $204 |
| E.R. Squibb & Sons, L.L.C. | 16 | $198 |
| Celgene Corporation | 14 | $194 |
| Incyte Corporation | 8 | $180 |
| GENZYME CORPORATION | 6 | $165 |
Products named: KEYTRUDA, Trodelvy, OPDIVO, KISQALI, REBLOZYL, SARCLISA, Fabhalta, VERZENIO.
Industry payments across TN — which companies pay providers there.
